Endpoints News

Oral peptides biotech Pinnacle Medicines gets $89M from US, China investors

Published

on

The pill version of Novo Nordisk’s blockbuster Wegovy showed what was possible when drug chemists turned peptides into oral molecules. Now investors have found their next related bet.

Pinnacle Medicines, a two-year-old startup based in …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version